Study Stopped
PI is retiring
Characterization and Brain Mechanisms of Frustration in Youth With Severe Irritability or Attention Deficit Hyperactivity Disorder (ADHD)
Characterization and Pathophysiology of Frustration in Pediatric Irritability
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
Background: Irritability is an elevated proneness to anger. Children with irritability have difficulty tolerating frustration. They get angry and have temper outbursts more easily than their others their age. Irritability is a symptom of DMDD and ADHD. (DMDD is disruptive mood dysregulation disorder. ADHD is attention deficit/hyperactivity disorder.) Yet the reasons why some children get irritated easily are not well understood. Objective: To use brain imaging methods to study responses to frustration in youth. Eligibility: Youth aged 8 to 17 years with severe irritability (including those diagnosed with DMDD) and/or ADHD. Healthy volunteers are also needed. All participants are already enrolled in studies 02-M-0021 or 01-M-0192. Design: Participants will visit the clinic 3 times. The second and third visits will be 3 to 4 weeks apart. The first visit will be an enrollment visit. They will receive training on the tasks they will do during the study. Participants and their parents will take surveys. They will answer questions about their moods and feelings. Participants will train for an MRI scan. They will lie in a mock scanner tube and hear the noises an MRI makes. On the second and third visits, participants will have real MRI scans. They will play a computer game or watch a movie during each scan. The scans will last about 1 hour. The week after each scan, participants will wear a device on their wrist to measure their heart rate and activity level. Participants and their parent will use a smartphone to answer questions about how they are feeling and acting. Participants who do not have smartphones will be given one to use during the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2022
CompletedFirst Posted
Study publicly available on registry
May 3, 2022
CompletedStudy Start
First participant enrolled
January 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2023
CompletedJanuary 10, 2023
January 1, 2023
Same day
April 29, 2022
January 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
prediction of irritability ratings by global efficiency
global efficiency of brain modules in resting state after frustration will be used to predict irritability ratings obtained throughout the one week after each of two scanning sessions
one week after each of two scanning sessions, when ecological momentary assessment ratings are completed. The two scanning sessions will be 2-5 weeks apart.
Variance of information (VIn) measures
VIn metric will be used to identify the brain modules making the largest contribution to network reconfiguration throughout frustration
data are obtained throughout each of the two scanning sessions. The two scanning sessions will be 2-5 weeks apart.
Secondary Outcomes (2)
ecological momentary assessment (EMA) measures
for one week after each of the two scanning sessions
Diffusion tensor imaging (DTI) metrics
during first scanning session
Study Arms (1)
frustration and control fMRI tasks
EXPERIMENTALall subjects complete one scanning session with frustration induction and one scanning session with the control task.
Interventions
During the frustration induction paradigm, children play a game with monetary reward. The game is rigged, thus inducing frustration. The control task does not have any reward component. All participants complete both the control task scanning session and the frustration induction scanning session.
Eligibility Criteria
You may qualify if:
- This study will include patients (i.e., youth with DMDD subthreshold DMDD, and/or ADHD) and healthy volunteers. All subjects will have already been enrolled in 02-M-0021 or 01-M-0192.
- Enrolled in 02-M-0021.
- Aged 8-17 at the time of recruitment.
- Healthy Volunteer Children
- Enrolled in 02-M-0021 or 01-M-0192 as a healthy volunteer.
- Aged 8-17 at the time of recruitment.
You may not qualify if:
- An individual who has contraindications for scanning will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ellen Leibenluft, M.D.
National Institute of Mental Health (NIMH)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2022
First Posted
May 3, 2022
Study Start
January 5, 2023
Primary Completion
January 5, 2023
Study Completion
January 5, 2023
Last Updated
January 10, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Starting six months after publication and ending five years later
- Access Criteria
- All data will be available that are allowable based on IRB-approved procedures.(SqrRoot)
.This study will comply with the NIH Data Sharing Policy and Policy on the Dissemination of NIH-Funded Clinical Trial Information and the Clinical Trials Registration and Results Information Submission rule. As such, this trial will be registered at ClinicalTrials.gov, and results information from this trial will be submitted to ClinicalTrials.gov. In addition, every attempt will be made to publish results in peer-reviewed journals.